Efficacy and safety of lazertinib in the treatment of EGFRmutated non-small cell lung cancer: a systematic review

被引：0
|
作者：
Gunawan, J. Evangeline [1 ]
机构：
[1] Pelita Harapan Univ, Dept Internal Med, Fac Med, Tangerang, Indonesia
来源：
ANNALS OF ONCOLOGY | 2024年 / 35卷
关键词：
D O I：
10.1016/j.annonc.2024.07.412
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P38-2
引用
收藏
页码：S1377 / S1377
页数：1
相关论文
共 50 条
  • [41] Efficacy and safety of immune checkpoint inhibitor rechallenge in non-small cell lung cancer: A systematic review and meta-analysis
    Feng, Yu
    Tao, Yunxia
    Chen, Haizhu
    Zhou, Yu
    Tang, Le
    Liu, Chenwei
    Hu, Xingsheng
    Shi, Yuankai
    THORACIC CANCER, 2023, 14 (25) : 2536 - 2547
  • [42] Efficacy and safety of neoadjuvant immunotherapy protocols and cycles for non-small cell lung cancer: a systematic review and meta-analysis
    Wang, Huaiyong
    Liang, Song
    Yu, Yue
    Han, Yun
    FRONTIERS IN ONCOLOGY, 2024, 14
  • [43] Safety and efficacy of retreatment with immune checkpoint inhibitors in non-small cell lung cancer: a systematic review and meta-analysis
    Cai, Zijing
    Zhan, Ping
    Song, Yong
    Liu, Hongbing
    Lv, Tangfeng
    TRANSLATIONAL LUNG CANCER RESEARCH, 2022, : 1555 - 1566
  • [44] Efficacy and Safety of Neoadjuvant Chemoimmunotherapy in Resectable Non-small Cell Lung Cancer (NSCLC): a systematic review and meta-analysis
    Syaj, S.
    Akhdar, M.
    Ababneh, O.
    Hamouri, S.
    JOURNAL OF THORACIC ONCOLOGY, 2022, 17 (09) : S235 - S236
  • [45] Efficacy and safety of immune checkpoint inhibitors in patients with advanced non-small cell lung cancer (NSCLC): a systematic literature review
    Wagner, Gernot
    Stollenwerk, Hannah Karolina
    Klerings, Irma
    Pecherstorfer, Martin
    Gartlehner, Gerald
    Singer, Josef
    ONCOIMMUNOLOGY, 2020, 9 (01):
  • [46] The Role of Lazertinib in Patients With EGFR-Variant Non-Small Cell Lung Cancer
    Cheng, Haiying
    JAMA ONCOLOGY, 2024, 10 (10) : 1352 - 1353
  • [47] A systematic review of targeted agents for non-small cell lung cancer
    Vestergaard, Hannah H.
    Christensen, Marcus R.
    Lassen, Ulrik N.
    ACTA ONCOLOGICA, 2018, 57 (02) : 176 - 186
  • [48] Gender Disparities in Non-Small Cell Lung Cancer: A Systematic Review
    Alsaadoun, Noor
    Kopciuk, Karen
    Hao, Desiree
    Riabowol, Karl
    Hollenbrg, Morley Hollenberg
    Bebb, Gwyn
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S352 - S353
  • [49] The safety of nivolumab for the treatment of advanced non-small cell lung cancer
    Metro, Giulio
    Ricciuti, Biagio
    Brambilla, Marta
    Baglivo, Sara
    Soli, Irene
    Minenza, Elisa
    Leonardi, Giulia Costanza
    D'arpino, Alessandro
    Colabrese, Daniela
    Tazza, Marco
    Zicari, Daniela
    Minotti, Vincenzo
    Chiari, Rita
    EXPERT OPINION ON DRUG SAFETY, 2017, 16 (01) : 101 - 109
  • [50] PROGRAMMED DEATH (PD)-1 AND PD-LIGAND-1 INHIBITORS IN THE TREATMENT OF NON-SMALL CELL LUNG CANCER: A SYSTEMATIC REVIEW OF THEIR EFFICACY AND SAFETY
    Lingohr-Smith, Melissa
    Deitelzweig, Chelsea
    Lin, Grace
    Lin, Jay
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2020, 8 : A337 - A337
12345